According to AllTheResearch’s analysis, the rising incidence of breast cancer and continuous technological improvements in the breast biopsy devices is expected to drive the growth of the ultrasound guided breast biopsy devices market ecosystem. However, few countries, such as France and Switzerland have recommended against population based screening for breast cancer. This may lead to a decrease in the number of breast biopsies being performed and therefore negatively impact the Ultrasound Guided Breast Biopsy Devices Market Ecosystem.
Get Sample Copy @ https://www.alltheresearch.com/sample-request/403
The U.S., Europe and China Ultrasound Guided Breast Biopsy Devices Market was valued at US$ 215.37 million in 2019 and is expected to grow at a CAGR of 3.1% until 2027. Companies such as NeoDynamics AB, have developed advanced products with its patented micropulse technology. The micropulse technology offer accurate lesion targeting and high tissue yield. Such products may revolutionize the ultrasound guided breast biopsy devices market ecosystem.
The major players operating in the ultrasound guided breast biopsy devices market ecosystem are Argon Medical Devices, Inc., Hologic, Inc., INRAD, Inc., Becton, Dickinson and Company, and Cook Group, Inc., amongst others. Mergers and acquisitions is one of the major strategy used by companies for entering in the Ultrasound guided breast biopsy devices market. For instance Becton, Dickinson and Company acquired C.R. Bard in 2017.
Based on product type, the core needle devices accounted for majority share in ultrasound guided breast biopsy devices in 2019. Core needle have a higher sensitivity when used with ultrasound and hence are the preferred device type under ultrasound guidance. Vacuum assisted biopsy devices have a high sample yield and hence are increasingly preferred by radiologists. Vacuum Assisted biopsy devices accounted for a share of 26.6% in 2019 and are expected to account for a share of 27.1% in the year 2027.
On the basis of needle type, disposable needles accounted for a majority share in market. The disposable needles are being increasingly used due to less chance of needle contamination and thereby spread of infection. More players in the market are increasingly offering disposable needles. The usage of these needles is particularly high in high-income countries, such as US, UK, Germany and other European countries.
Europe dominated the market in 2019 and is expected to maintain its pole position throughout the forecast period. Chinese market is witnessing a shift from invasive biopsies to minimally invasive biopsies which is driving the growth of the Ultrasound breast biopsy devices market in this region. Therefore, China is an attractive region for investment for biopsy device manufacturers.